Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: Poland Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20051
20063
20073
20082
20091
20112
20122
20142
20152
20162
20178
20183
20194
20202
20217
20224
20233
20247
20257
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting18
Active, not recruiting15
Terminated8
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen8
Boehringer Ingelheim5
Hoffmann-La Roche5
AstraZeneca4
Bristol-Myers Squibb4
GlaxoSmithKline4
Merck Sharp & Dohme LLC4
AbbVie3
Celgene3
Eli Lilly and Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma77
Carcinoma, Non-Small-Cell Lung11
Lung Neoplasms9
Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Hepatocellular2
Carcinoma, Small Cell2
Melanoma2
Neoplasm Metastasis2
Triple Negative Breast Neoplasms2

Trials

Showing 26 to 50 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.